What is Citius Pharma?
Citius Pharma is a late-stage biopharmaceutical entity focused on the development and commercialization of critical care products. Its therapeutic areas of interest span oncology, adjunct cancer care, unique prescription products, and stem cell therapies. Established in 2007 and headquartered in Cranford, New Jersey, the company is strategically positioned to address unmet needs in demanding medical fields.
How much funding has Citius Pharma raised?
Citius Pharma has raised a total of $20.1M across 2 funding rounds:
Debt
$150K
Share Placement
$20M
Debt (2020): $150K with participation from PPP
Share Placement (2021): $20M, investors not publicly disclosed
What's next for Citius Pharma?
The substantial enterprise-level funding Citius Pharma has garnered indicates a pivotal phase of growth and development. This capital infusion is expected to accelerate the advancement of its product pipeline, potentially enabling the company to move through late-stage clinical trials and prepare for commercialization. The strategic nature of recent financing suggests a focus on enhancing operational capabilities and market penetration, positioning Citius Pharma for significant expansion in the competitive biopharmaceutical landscape.
See full Citius Pharma company page
